stimulon


Also found in: Medical, Wikipedia.

stimulon

[′stim·yə‚län]
(genetics)
A system of genes not physically linked together.
References in periodicals archive ?
Sales of Shingrix, containing our QS-21 Stimulon, continue to increase; GSK projects 2019 sales will exceed $1.3Bn
Immuno-oncology company Agenus Inc (NASDAQ:AGEN) reported on Thursday the receipt of the Bill & Melinda Gates Foundation's USD1m grant to jointly develop an alternative, plant cell culture-based manufacturing process to ensure the continuous future supply of its QS-21 Stimulon adjuvant to power vaccines.
The experiment of portable head eye tracker combined with pictures is very difficult for users to concentrate due to the large error of eye movement data and the small size of stimulon. The virtual reality scene can be observed in 360 degrees, and the subjects' perspective is large, which can not be constrained by the size of picture.
Nystorm, "Glucose starvation stimulon of Escherichia coli: role of integration host factor in starvation survival and growth phase-dependent protein synthesis," Journal of Bacteriology, vol.
The company's QS-21 Stimulon adjuvant is extensively partnered with GlaxoSmithKline and Janssen Sciences Ireland UC, and two vaccine candidates containing QS-21 have successfully completed Phase 3 trials.
(49.) E, E Nicholas et al.Genome-Wide Transcriptional Analysis of the Phosphate Starvation Stimulon of Bacillus subtilis [En linea] 2005 [Fecha de acceso 13 de Octubre de 2013]; 187(23).
Lee et al., "The [H.sub.2][O.sub.2] stimulon in Saccharomyces cerevisiae" The Journal of Biological Chemistry, vol.
-- Phase 2: Prophage Series G-100 for newly diagnosed glioma -- Phase 2: Prophage Series G-200 for recurrent glioma -- Phase 2 Ready: HerpV (contains QS-21 Stimulon) for genital herpes
Godon, C, Lagniel, C, Lee, J., Buhler, J., Kieffer, S., Perrot, M., Boucherie, H., Toledano, M., Labarre, J., 1998.The [H.sub.2][O.sub.2] Stimulon in Saccharomyces cerevisiae.
(Framingham, MA; 508-766-2700) announced that the Opposition Division of the European Patent Office has affirmed the validity of the claims in Aquila's European patent covering the use of its Stimulon adjuvants, including QS-21 and QS-7.